PharmaTimesNews & Politicsnews

Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis

Tuesday, May 26, 2026John PinchingView original

Findings strengthen rationale for EMERALD trial of engineered macrophage therapy RTX001

Read the full article on the original site.